These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 34728176)

  • 1. Simulate SubQ: The Methods and the Media.
    Li D; Chow PY; Lin TP; Cheow C; Li Z; Wacker MG
    J Pharm Sci; 2023 Jun; 112(6):1492-1508. PubMed ID: 34728176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biopredictive tools for the development of injectable drug products.
    Villa Nova M; Gan K; Wacker MG
    Expert Opin Drug Deliv; 2022 Jun; 19(6):671-684. PubMed ID: 35603724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Biopredictive In Vitro Comparison of Oral Locally Acting Mesalazine Formulations by a Novel Dissolution Model for Assessing Intraluminal Drug Release in Individual Subjects.
    Karkossa F; Klein S
    J Pharm Sci; 2018 Jun; 107(6):1680-1689. PubMed ID: 29499277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a Physiologically Relevant Population Pharmacokinetic in Vitro-in Vivo Correlation Approach for Designing Extended-Release Oral Dosage Formulation.
    Kim TH; Shin S; Bulitta JB; Youn YS; Yoo SD; Shin BS
    Mol Pharm; 2017 Jan; 14(1):53-65. PubMed ID: 27809538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biorelevant dissolution testing and physiologically based absorption modeling to predict in vivo performance of supersaturating drug delivery systems.
    Thakore SD; Sirvi A; Joshi VC; Panigrahi SS; Manna A; Singh R; Sangamwar AT; Bansal AK
    Int J Pharm; 2021 Sep; 607():120958. PubMed ID: 34332060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulatory perspectives on in vitro (dissolution)/in vivo (bioavailability) correlations.
    Uppoor VR
    J Control Release; 2001 May; 72(1-3):127-32. PubMed ID: 11389991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a Clinically Relevant Dissolution Method for Metaxalone Immediate Release Formulations Based on an IVIVC Model.
    Vuletić L; Khan MZI; Špoljarić D; Radić M; Cetina-Čižmek B; Filipović-Grčić J
    Pharm Res; 2018 Jun; 35(8):163. PubMed ID: 29934663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro models for the prediction of in vivo performance of oral dosage forms.
    Kostewicz ES; Abrahamsson B; Brewster M; Brouwers J; Butler J; Carlert S; Dickinson PA; Dressman J; Holm R; Klein S; Mann J; McAllister M; Minekus M; Muenster U; Müllertz A; Verwei M; Vertzoni M; Weitschies W; Augustijns P
    Eur J Pharm Sci; 2014 Jun; 57():342-66. PubMed ID: 23988843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physiologically Based In vitro Models to Predict the Oral Dissolution and Absorption of a Solid Drug Delivery System.
    Li Z; He X
    Curr Drug Metab; 2015; 16(9):777-806. PubMed ID: 26264200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro - in vivo correlation: from theory to applications.
    Emami J
    J Pharm Pharm Sci; 2006; 9(2):169-89. PubMed ID: 16959187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dissolution testing of oral modified-release dosage forms.
    Garbacz G; Klein S
    J Pharm Pharmacol; 2012 Jul; 64(7):944-68. PubMed ID: 22686342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of In Vitro Dissolution Testing Methods to Simulate Fed Conditions for Immediate Release Solid Oral Dosage Forms.
    Lex TR; Rodriguez JD; Zhang L; Jiang W; Gao Z
    AAPS J; 2022 Mar; 24(2):40. PubMed ID: 35277760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Perspective on Model-Informed IVIVC for Development of Subcutaneous Injectables.
    Corpstein CD; Li T
    Pharm Res; 2023 Jul; 40(7):1633-1639. PubMed ID: 37523013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening of Bioequivalent Extended-Release Formulations for Metformin by Principal Component Analysis and Convolution-Based IVIVC Approach.
    Zhang Y; Liu H; Tang MJ; Ho NJ; Shek TL; Yang Z; Zuo Z
    AAPS J; 2021 Mar; 23(2):38. PubMed ID: 33665728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Harmonizing Biopredictive Methodologies Through the Product Quality Research Institute (PQRI) Part I: Biopredictive Dissolution of Ibuprofen and Dipyridamole Tablets.
    Tsume Y; Ashworth L; Bermejo M; Cheng J; Cicale V; Dressman J; Fushimi M; Gonzalez-Alvarez I; Guo Y; Jankovsky C; Lu X; Matsui K; Patel S; Sanderson N; Sun CC; Thakral NK; Yamane M; Zöller L
    AAPS J; 2023 Apr; 25(3):45. PubMed ID: 37085637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of the enhanced oral bioavailability of fenofibrate lipid formulations in fasted humans using an in vitro-in silico-in vivo approach.
    Fei Y; Kostewicz ES; Sheu MT; Dressman JB
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1274-84. PubMed ID: 23500116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biorelevant in-vitro performance testing of orally administered dosage forms.
    Reppas C; Vertzoni M
    J Pharm Pharmacol; 2012 Jul; 64(7):919-30. PubMed ID: 22686340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicting drug release and degradation kinetics of long-acting microsphere formulations of tacrolimus for subcutaneous injection.
    Gao GF; Ashtikar M; Kojima R; Yoshida T; Kaihara M; Tajiri T; Shanehsazzadeh S; Modh H; Wacker MG
    J Control Release; 2021 Jan; 329():372-384. PubMed ID: 33271202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Formulation predictive dissolution (fPD) testing to advance oral drug product development: An introduction to the US FDA funded '21st Century BA/BE' project.
    Hens B; Sinko PD; Job N; Dean M; Al-Gousous J; Salehi N; Ziff RM; Tsume Y; Bermejo M; Paixão P; Brasseur JG; Yu A; Talattof A; Benninghoff G; Langguth P; Lennernäs H; Hasler WL; Marciani L; Dickens J; Shedden K; Sun D; Amidon GE; Amidon GL
    Int J Pharm; 2018 Sep; 548(1):120-127. PubMed ID: 29944899
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Silva TMD; Honorio TDS; Chaves MHDC; Duque MD; Cabral LM; Patricio BFC; Rocha HVA
    Drug Dev Ind Pharm; 2021 Aug; 47(8):1342-1352. PubMed ID: 34622730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.